OPTUNE® TREATMENT FOR
GLIOBLASTOMA (GBM)
OPTUNE LUA™ TREATMENT FOR
MESOTHELIOMA (MPM)
Intended for US healthcare professionals only.
Optune® logo Novocure™ logo
Practice support Patient support Skin AE management Resources FAQs Peer-reviewed publications Video library Calendar of events

Resources

In this section, you'll find a variety of resources to help you better understand Optune, share this novel treatment with your patients who have newly diagnosed or recurrent glioblastoma (GBM), and start prescribing Optune.

Print Resources For Your Practice

Long-term quality survival brochure

Long-term Quality Survival brochure

Learn about Optune + TMZ for patients with newly diagnosed GBM.

View this PDF
Optune® Dialogue Tool

Introducing Optune Dialogue Tool

Find patient-friendly language to assist you in discussing Optune with patients and caregivers.

View this PDF
nCompass™ brochure

nCompass Brochure

See the nCompass brochure for more information and patient support to learn how nCompass supports patients at every step of their journey.

View this PDF
Optune® Post-Hoc Analysis in Elderly Patients

Optune for Elderly Patients

Learn about Optune + TMZ in elderly patients with histologically-confirmed, newly diagnosed GBM.

View this PDF
Management Guidelines for Dermatologic Adverse Events (dAEs) brochure

Management Guidelines for Dermatologic Adverse Events (dAEs) brochure

This brochure provides guidance to you and your practice for identifying, preventing, and managing dAEs for Optune users.

View this PDF
Monthly usage fact sheet

Monthly usage fact sheet

Learn how a greater survival benefit was achieved with increased Optune use.

View this PDF
Optune® Post-Hoc Analysis in Biopsy-Only Patients

Optune for Biopsy-Only Patients

Learn about Optune + TMZ in biopsy-only patients

View this PDF

Print Resources For Patients

First glance at Optune®

First Glance at Optune

Provides a high-level overview of Optune, including clinical efficacy, how to obtain and properly use Optune, and the nCompass Support Program.

View this PDF
Buddy Program brochure for Optune® users

Buddy Program brochure

Explains the peer-to-peer patient program that connects Optune users and patients/caregivers who are considering, are about to start, or have recently started Optune.

View this PDF
Understanding Optune®

Understanding Optune

A comprehensive guide about Optune and how patients can integrate treatment into their daily routines.

View this PDF
nCompass™ Patient brochure

nCompass Patient brochure

An in-depth look at nCompass from the first Welcome Call to ongoing support and education throughout treatment.

View this PDF
MyLink™ Quick Reference Card

My Link Quick Reference Card

Introduces patients to the MyLink hardware and provides a step-by-step guide of how to use it.

View this PDF
Optune® Patient Scalp Care Guidelines

Patient Scalp Care Guidelines

Answers your patients’ questions about scalp care and transducer array placement.

View this PDF
Optune® Troubleshooting Tips

Optune Troubleshooting Tips

A guide for patients and caregivers to refer to when the Optune device alarm goes off to easily determine and address the cause.

View this PDF
Patient Travel Support by nCompass™ brochure

Patient Travel Support by nCompass brochure

Answers frequently asked questions about travel and provides checklists of what to pack and bring when traveling with Optune.

View this PDF

Additional Resources

Peer-reviewed publications

Peer-reviewed publications

Review various publications about Optune.

See publications
Calendar of events

Calendar of events

Optune open houses and events focused on brain cancer.

See upcoming events

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).